Guerbet Recalls Sodium Chloride Syringes Due to RFID Formatting Error
Guerbet LLC is recalling 3,140 prefilled sodium chloride syringes because an RFID formatting error prevents the Optivantage injector from administering the product.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a technical RFID error preventing administration, not a safety hazard like contamination or injury.
Plain-English summary
Guerbet LLC is recalling 3,140 units of Sodium Chloride Injection USP 0.9% packaged in 125 mL Ultraject Prefilled Syringes. The recall involves lots L159A (exp. 06/2021) and L169A (exp. 07/2021), which were distributed nationwide in the United States. The product is manufactured by Liebel-Flarsheim Company LLC and is intended for intravascular use.
The recall was initiated due to a labeling issue involving an RFID formatting error. This error causes the product to be read as expired by the Optivantage injector, which prevents the injection of the product. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
Healthcare providers and facilities that have received these specific lots should stop using the affected syringes and contact the recalling firm for instructions on return or disposal. Patients who have already received the product should contact their healthcare provider if they have questions or concerns.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- GUERBET LLC
- Category
- Drug — Injection
- Hazard
- Affected units
- 3,140
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots: L159A
- Exp. 06/2021
- L169A
- Exp. 07/2021
UPCs (1)
- 0300191188816
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by GUERBET LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · SODIUM CHLORIDE
- HighSpectra sodium chloride ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighFresenius Kabi 250 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 1,000 mL sodium chloride bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 50 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighBD-distributed 50 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
Same manufacturer · GUERBET LLC
See all →- ModerateGuerbet Recalls Optiray Syringes Due to RFID Formatting Error
FDA (Drugs) · 2019-10-16
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02